BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6000275)

  • 1. [The use of an adrenergic beta-receptor blocking agent in coronary insufficiency and heart rhythm disorders].
    Doshchitsyn VL
    Kardiologiia; 1966; 6(5):65-9. PubMed ID: 6000275
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy with beta-blocking agents in cardiology].
    Dal Palù C
    Minerva Med; 1970 Nov; 61(95):5450-8. PubMed ID: 4395227
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the use of beta-adrenoreceptor blocking agents in patients with coronary insufficiency with disorders of heart rhythm].
    Anshelevich IuV; Gol'dberg TO; Beer ET
    Ter Arkh; 1967 Sep; 39(9):98-100. PubMed ID: 5611712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta adrenergic receptor blocking agents in the treatment of arrhythmia and angina pectoris].
    Fülöp T; Szodoray P
    Orv Hetil; 1969 Oct; 110(41):2387-94. PubMed ID: 5358359
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta blocking therapy in cardiac rhythm disorders and angina pectoris].
    Di Matteo J; Vacheron A; Heulin A
    Therapeutique; 1972 Feb; 48(2):101-4. PubMed ID: 4403141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the effects of beta-adrenergic blocking in heart diseases, with special reference to disorders of rhythm and circulation].
    Fassini G; Saurgnani E; Agliati G; Marangoni R
    Minerva Cardioangiol; 1967 Jan; 15(1):83-122. PubMed ID: 4386133
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
    Piva M; Ongari R; Dotti F
    Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenergic beta-receptor blocking agents in the treatment of cardiothyreosis (arrhythmias, angina pectoris)].
    Popovici D
    Stud Cercet Endocrinol; 1969; 20(1):63-74. PubMed ID: 5343647
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anaprilin in stenocardia and arrhythmia].
    Zharko KP; Lebedev SV; Simon IB
    Klin Med (Mosk); 1972 Feb; 50(2):57-60. PubMed ID: 4401948
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of anaprilin on hemodynamics and cardiac rhythm].
    Zharko KP
    Vrach Delo; 1971 Jul; 7():33-6. PubMed ID: 4399348
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of coronary insufficiency with beta-adrenergic blocking agents].
    De Maestri C; Rinaldi AR
    Boll Soc Med Chir Cremona; 1967; 21(3):125-32. PubMed ID: 5597563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Positive and negative effects of beta-adrenergic blocking in angina pectoris. (Indications on the contemporary use of nitroglycerin and aminophylline)].
    Starcich R; Barbaresi F; Volta G; Pavarani A
    Minerva Cardioangiol; 1967 Dec; 15(12):835-43. PubMed ID: 4975623
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenergic beta blocking agents].
    Policlinico Prat; 1969 May; 76(18):584-8. PubMed ID: 4396175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.